Back
Inogen 10K Form
Sell
21
INGN
Inogen
Last Price:
6.75
Seasonality Move:
4.62%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-09 | 10Q | INGN/Inogen Quarterly |
2023-08-08 | 10Q | INGN/Inogen Quarterly |
2023-05-05 | 10Q | INGN/Inogen Quarterly |
2022-11-03 | 10Q | INGN/Inogen Quarterly |
2022-08-04 | 10Q | INGN/Inogen Quarterly |
2022-05-05 | 10Q | INGN/Inogen Quarterly |
Receive INGN News And Ratings
See the #1 stock for the next 7 days that we like better than INGN
INGN Financial Statistics
Sales & Book Value
Annual Sales: | $315.66M |
---|---|
Cash Flow: | $-9.45M |
Price / Cash Flow: | 0 |
Annual Sales: | $8.93 |
Price / Book: | 0.77 |
Profitability
EPS (TTM): | -4.41000 |
---|---|
Net Income (TTM): | $-102.45M |
Gross Margin: | $126.7M |
Return on Equity: | -39.74% |
Return on Assets: | -27.92% |
Inogen Earnings Forecast
Key Inogen Financial Ratios
- The Gross Profit Margin over the past 20 years for INGN is 40.14%.
- The Selling, General & Administrative Expenses for INGN have been equal to 57.77% of Gross Profit Margin.
- The Research & Development expenses have been 6.60% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of INGN is -32.46% of Total Revenues.
- Per Share Earnings over the last 20 years have been positive in 10 years.
Inogen Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Health Care Equipment & Supplies |
Sector: | Health Care |
Current Symbol: | INGN |
CUSIP: | 45780L |
Website: | inogen.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 2.86 |
Quick Ratio: | 2.36 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |